Home Cart 0 Sign in  
X

[ CAS No. 5274-99-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5274-99-7
Chemical Structure| 5274-99-7
Chemical Structure| 5274-99-7
Structure of 5274-99-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5274-99-7 ]

Related Doc. of [ 5274-99-7 ]

Alternatived Products of [ 5274-99-7 ]

Product Details of [ 5274-99-7 ]

CAS No. :5274-99-7 MDL No. :MFCD00040747
Formula : C13H15NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :ZTGMNCCDDKBPML-UHFFFAOYSA-N
M.W : 233.26 Pubchem ID :78935
Synonyms :

Calculated chemistry of [ 5274-99-7 ]

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.38
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 67.14
TPSA : 57.61 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.72
Log Po/w (XLOGP3) : 1.38
Log Po/w (WLOGP) : 1.24
Log Po/w (MLOGP) : 1.59
Log Po/w (SILICOS-IT) : 1.38
Consensus Log Po/w : 1.46

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.22
Solubility : 1.41 mg/ml ; 0.00604 mol/l
Class : Soluble
Log S (Ali) : -2.19
Solubility : 1.5 mg/ml ; 0.00641 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.22
Solubility : 1.4 mg/ml ; 0.00601 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.73

Safety of [ 5274-99-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5274-99-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5274-99-7 ]
  • Downstream synthetic route of [ 5274-99-7 ]

[ 5274-99-7 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 498-94-2 ]
  • [ 98-88-4 ]
  • [ 5274-99-7 ]
YieldReaction ConditionsOperation in experiment
94% With hydrogenchloride; triethylamine In tetrahydrofuran at 70℃; for 0.25 h; Microwave irradiation A mixture of isonipecotic acid 1 (129 mg, 1.0 mmol), benzoyl chloride 2 (140 mg, 1.0 mmol) and Et3N (0.32 mL, 2.5 mmol) in THF (5 mL) was stirred under microwave irradiation (120 W) at 70 °C for 15 min. The reaction mixture was acidified using 1 M HCl (10 mL) and extracted with dichloromethane (3 * 25 mL). The combined organic layers were dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by flash column chromatography using 5percent ethyl acetate in hexane, followed by 80percent ethyl acetate in hexane as eluent to yield 3 (94percent) as white solid. Mp 136-138 °C. 1H NMR (400 MHz, CDCl3) δ 1.71-1.85 (m, 3H), 2.03-2.06 (m, 1H), 2.59 (tt, 1H, J = 10.4, 4.1 Hz), 3.04-3.12 (m, 2H), 3.72-3.76 (m, 1H), 4.48-4.52 (m, 1H), 7.36-7.44 (m, 5H), 11.16 (br s, 1H). 13C NMR (100 MHz, CDCl3) δ 40.4, 41.4, 46.8, 126.7, 128.3, 129.6, 135.3, 170.7, 178.3. HRMS (ESI): calcd for C13H14NO3 [M-H]-, 232.0973; found, 232.0979.
85%
Stage #1: With potassium carbonate In tetrahydrofuran; water at 0 - 20℃; for 22 h;
Stage #2: With hydrogenchloride In water at 0℃;
To a 250-mL round-bottomed flask equipped with a stirring bar, isonipecotic acid (10.000 g, 77.425 mmol,1.0 equiv) was added. THF (80 mL), H2O (80 mL) and K2CO3 (53.504 g, 387.121 mmol, 5.0 equiv) were added, and the mixture was cooled to 0°C. A solution of benzoyl chloride (8.980 mL, 77.425 mmol, 1.0 equiv) in THF (35mL) was added drop-wise. The reaction mixture was allowed to warm to r.t. and then stirred for 22 h. The reaction mixture was transferred into a 500-mLseparating funnel and washed with EtOAc (3 × 150 mL). The aqueous phase was cooled to 0 °C and adjusted to pH 1-2 with 6 M aq HCl. The white precipitate was collected in a Büchner funnel under suction filtration, and then dried in vacuo at room temperature in the presence of NaOH, P2O5 and silica gel to constant mass to produce 15.369 g of 12 as a white solid (85percentyield). This product was used in the next step without further purification. Rf = 0.55 (MeCN-H2O-MeOH= 3:1:1); mp 118–122 °C. IR (ATR): 2857, 2359, 1730, 1612, 1447, 1207, 1169,1014, 791, 731, 707, 628, 577. cm-1. 1H NMR (400 MHz,DMSO-d6): δ = 1.49 (2 H, bs), 1.83 (2 H, bd, J = 45.68 Hz), 2.52–2.57 (1 H, m), 3.01 (2 H, bd, J = 52.08 Hz), 3.52 (1 H, bs), 4.31 (1H, bs), 7.34–7.46 (5 H, m), 12.32 (1 H, bs). 13C NMR (100 MHz,DMSO-d6): δ = 27.62, 28.24, 40.06, 40.74, 46.38, 126.61, 128.38, 129.31,136.23, 168.96, 175.481. HRMS (ESI+): m/z calcd for C13H16NO3: 234.1130; found 231.1125. Anal. Calcd for C13H15NO3: C,66.94; H, 6.48; N, 6.00. Found C, 67.22; H, 6.78; 6.22.
85% With potassium carbonate In tetrahydrofuran; water at 0 - 20℃; for 22 h; To a 250-mL round-bottomed flask equipped with a stirring bar, isonipecotic acid (10.000 g, 77.425 mmol) was added. THF (80 mL), H2O (80 mL) and K2CO3 (53.504 g, 387.121 mmol) were added, and the mixture was cooled to 0 °C. A solution of benzoyl chloride (8.980 imL, 77.425 mmol) in THF (35 imL) was added drop-wise. The reaction mixture was allowed to warm to r.t. and then stirred for 22 h. The reaction mixture was transferred into a 500-mL separating funnel and washed with EtOAc (3 χ 150 ml_). The aqueous phase was cooled to 0 °C and adjusted to pH 1 -2 with 6 M aq HCI. The white precipitate was collected in a Buchner funnel under suction filtration, and then dried in vacuo at room temperature in the presence of NaOH, P2O5 and silica gel to constant mass to produce 15.369 g of 1 -benzoylpiperidine-4-carboxylic acid. This product was used in the next step without further purification.Product appearance: white solid.Yield: 85percent.Melting point: 1 18-122 °C . TLC: Rf = 0.55 (MeCN-H2O-MeOH = 3:1 :1 ) .IR (ATR): 2857, 2359, 1730, 1612, 1447, 1207, 1 169, 1014, 791 , 731 , 707, 628, 577. cm"1 (0361) [0333] 1H NMR (400 MHz, DMSO-d6): δ = 1 .49 (2 H, bs), 1 .83 (2 H, bd, J = 45.68 Hz), 2.52-2.57 (1 H, m), 3.01 (2 H, bd, J = 52.08 Hz), 3.52 (1 H, bs), 4.31 (1 H, bs), 7.34-7.46 (5 H, m), 12.32 (1 H, bs).13C NMR (100 MHz, DMSO-d6): δ = 27.62, 28.24, 40.06, 40.74, 46.38, (0363) 126.61 , 128.38, 129.31 , 136.23, 168.96, 175.48.HRMS (ESI+): m/z calculated for C13H16NO3: 234.1 130; found 231 .1 125. CHN analysis: Calculated for C13H15NO3: C, 66.94; H, 6.48; N, 6.00. Found: (0366) C, 67.22; H, 6.78; N, 6.22.
Reference: [1] Bioorganic Chemistry, 2018, vol. 80, p. 245 - 252
[2] Tetrahedron Letters, 2014, vol. 55, # 12, p. 2037 - 2039
[3] Patent: WO2016/151484, 2016, A1, . Location in patent: Paragraph 0327
[4] Journal of Medicinal Chemistry, 2018, vol. 61, # 1, p. 119 - 139
[5] Patent: US5948786, 1999, A,
[6] Patent: US6248755, 2001, B1,
[7] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 8, p. 2305 - 2308
[8] Journal of the American Chemical Society, 2015, vol. 137, # 17, p. 5654 - 5657
[9] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 2, p. 633 - 645
  • 2
  • [ 136081-74-8 ]
  • [ 5274-99-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 20, p. 8066 - 8096
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 18, p. 4639 - 4642
[3] Journal of Medicinal Chemistry, 2009, vol. 52, # 5, p. 1358 - 1369
[4] Journal of Medicinal Chemistry, 2010, vol. 53, # 7, p. 2825 - 2835
  • 3
  • [ 1126-09-6 ]
  • [ 5274-99-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 18, p. 4639 - 4642
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 20, p. 8066 - 8096
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5274-99-7 ]

Aryls

Chemical Structure| 744212-68-8

[ 744212-68-8 ]

1-Benzyl-5-(hydroxymethyl)piperidin-2-one

Similarity: 0.83

Chemical Structure| 10315-07-8

[ 10315-07-8 ]

1-Benzylpiperidine-4-carboxylic acid

Similarity: 0.81

Chemical Structure| 352673-16-6

[ 352673-16-6 ]

1-(2-Chlorobenzoyl)piperidine-4-carboxylic acid

Similarity: 0.79

Chemical Structure| 63610-08-2

[ 63610-08-2 ]

2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid

Similarity: 0.79

Chemical Structure| 10315-06-7

[ 10315-06-7 ]

Methyl 1-benzylpiperidine-4-carboxylate

Similarity: 0.77

Amides

Chemical Structure| 744212-68-8

[ 744212-68-8 ]

1-Benzyl-5-(hydroxymethyl)piperidin-2-one

Similarity: 0.83

Chemical Structure| 75513-35-8

[ 75513-35-8 ]

3-(1,3-Dioxo-3,4-dihydroisoquinolin-2(1H)-yl)propanoic acid

Similarity: 0.79

Chemical Structure| 352673-16-6

[ 352673-16-6 ]

1-(2-Chlorobenzoyl)piperidine-4-carboxylic acid

Similarity: 0.79

Chemical Structure| 3339-73-9

[ 3339-73-9 ]

3-(1,3-Dioxoisoindolin-2-yl)propanoic acid

Similarity: 0.79

Chemical Structure| 63610-08-2

[ 63610-08-2 ]

2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid

Similarity: 0.79

Carboxylic Acids

Chemical Structure| 10315-07-8

[ 10315-07-8 ]

1-Benzylpiperidine-4-carboxylic acid

Similarity: 0.81

Chemical Structure| 75513-35-8

[ 75513-35-8 ]

3-(1,3-Dioxo-3,4-dihydroisoquinolin-2(1H)-yl)propanoic acid

Similarity: 0.79

Chemical Structure| 352673-16-6

[ 352673-16-6 ]

1-(2-Chlorobenzoyl)piperidine-4-carboxylic acid

Similarity: 0.79

Chemical Structure| 3339-73-9

[ 3339-73-9 ]

3-(1,3-Dioxoisoindolin-2-yl)propanoic acid

Similarity: 0.79

Chemical Structure| 63610-08-2

[ 63610-08-2 ]

2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid

Similarity: 0.79

Related Parent Nucleus of
[ 5274-99-7 ]

Aliphatic Heterocycles

Chemical Structure| 744212-68-8

[ 744212-68-8 ]

1-Benzyl-5-(hydroxymethyl)piperidin-2-one

Similarity: 0.83

Chemical Structure| 10315-07-8

[ 10315-07-8 ]

1-Benzylpiperidine-4-carboxylic acid

Similarity: 0.81

Chemical Structure| 352673-16-6

[ 352673-16-6 ]

1-(2-Chlorobenzoyl)piperidine-4-carboxylic acid

Similarity: 0.79

Chemical Structure| 10315-06-7

[ 10315-06-7 ]

Methyl 1-benzylpiperidine-4-carboxylate

Similarity: 0.77

Chemical Structure| 141943-04-6

[ 141943-04-6 ]

1-Benzylpiperidine-3-carboxylic acid

Similarity: 0.77

Piperidines

Chemical Structure| 744212-68-8

[ 744212-68-8 ]

1-Benzyl-5-(hydroxymethyl)piperidin-2-one

Similarity: 0.83

Chemical Structure| 10315-07-8

[ 10315-07-8 ]

1-Benzylpiperidine-4-carboxylic acid

Similarity: 0.81

Chemical Structure| 352673-16-6

[ 352673-16-6 ]

1-(2-Chlorobenzoyl)piperidine-4-carboxylic acid

Similarity: 0.79

Chemical Structure| 10315-06-7

[ 10315-06-7 ]

Methyl 1-benzylpiperidine-4-carboxylate

Similarity: 0.77

Chemical Structure| 141943-04-6

[ 141943-04-6 ]

1-Benzylpiperidine-3-carboxylic acid

Similarity: 0.77